| |
 |
Can PPARγ Ligands Be Used in Cancer Therapy?
|
| |
|
pp.465-477 (13) Authors: M. A.K. Rumi, S. Ishihara, H. Kazumori, Y. Kadowaki, Y. Kinoshita |
| |
|
|
| |
|
Cytoprotection and Immunomodulation in Cancer Therapy
|
| |
|
pp.479-490 (12) Authors: Sham Diwanay, Manish Gautam, Bhushan Patwardhan |
| |
|
|
| |
|
Multiple Targeting by the Antitumor Drug Tamoxifen: A Structure-Activity Study
|
| |
|
pp.491-508 (18) Authors: Philippe de Medina, Gilles Favre, Marc Poirot |
| |
|
|
| |
|
Biological Targets of Antitumor Indolocarbazoles Bearing a Sugar Moiety
|
| |
|
pp.509-521 (13) Author: Michelle Prudhomme |
| |
|
|
| |
|
Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
|
| |
|
pp.523-534 (12) Authors: J. Narashimamurthy, A. Raghu Ram Rao, G. Narahari Sastry |
| |
|
|
| |
|
Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies
|
| |
|
pp.535-542 (8) Authors: Sonya Trombino, Alessandra Bisio, Alessia Catassi, Alfredo Cesario, Carla Falugi, Patrizia Russo |
| |
|
|
| |
|
An Update on the Systemic Therapy of Malignant Salivary Gland Cancers: Role of Chemotherapy and Molecular Targeted Agents
|
| |
|
pp.543-551 (9) Authors: M. Agulnik, L. L. Siu |
| |
|
|
